Source comparison
Comparison Table: Melanotan-2 Dosing Protocols for Sexual Health
The following table compares maintenance, acute event, and combination protocols across key variables that determine efficacy and tolerability. | Protocol Type | Dose & Frequency | Onset to Effect | Peak Arousal Window | Nausea Incidence | Best Use Case | Prof
This comparison does not assign a generated winner or score.
- The following table compares maintenance, acute event, and combination protocols across key variables that determine efficacy and tolerability.
- | Protocol Type | Dose & Frequency | Onset to Effect | Peak Arousal Window | Nausea Incidence | Best Use Case | Professional Assessment ||—|—|—|—|—|—|| Maintenance (Low-Dose Chronic) | 100–250mcg daily or every 48 hours | 5–10 days to baseline effect | Sustained elevation, no discrete peak | 15–25% (diminishes after week 1) | Relationship-based spontaneous desire; users who dislike event planning | Reliable for baseline libido restoration; less dramatic than acute dosing but integrates into daily life without scheduling || Acute Event (High-Dose Pre-Activity) | 0.5–1.5mg 2–4 hours before activity | 90–120 minutes (subjective), 3–4 hours (peak erectile) | 3–6 hours post-injection | 50–70% at 1mg+ (mitigated with antiemetic pre-dosing) | Scheduled encounters; users seeking maximal peak-window effect | Produces strongest subjective arousal and erectile quality; requires planning and side effect tolerance || Combination (Maintenance + Acute Boost) | 100mcg daily + 0.5–1mg event dose as nee